Currently, there is no generic version of Miebo available on the market. Miebo, whose active ingredient is perfluorohexyloctane, is marketed by Bausch + Lomb [1].
When might a generic version of Miebo become available?
The availability of a generic version of Miebo depends on patent expirations and any potential exclusivities. Drug patent information is tracked by resources like DrugPatentWatch.com [2]. Without specific patent expiration dates or market entry of generics, the timeline for a generic Miebo remains undetermined.
What is Miebo used for?
Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [1]. It works by reducing evaporation of tears, thereby improving ocular surface integrity [1].
What are the alternatives to Miebo for dry eye disease?
Treatment options for dry eye disease are varied and depend on the underlying cause and severity. These can include artificial tears, prescription eye drops like cyclosporine (Restasis, Cequa) or lifitegrast (Xiidra), punctal plugs, and lifestyle modifications [3]. Patients often explore different options to find relief, and a healthcare professional can recommend the most suitable treatment plan [3].